Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Determination of Brain Volumes Using Quantitative MR Imaging in Patients with Multiple Sclerosis.
Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis.
Graph theoretical analysis indicates cognitive impairment in MS stems from neural disconnection.
Myelin Basic Protein-primed T Helper 2 Cells Suppress Microglial Activation via AlphaVBeta3 Integrin: Implications for Multiple Sclerosis.
Carbon Monoxide and Central Nervous System: Challenges and Achievements.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Dementia in MS complicated by coexistent Alzheimer disease: Diagnosis premortem and postmortem.
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: No.
Intrathecal synthesis in particular types of multiple sclerosis.
Cortisol awakening response is linked to disease course and progression in multiple sclerosis.
[Multiple sclerosis and pregnancy].
GABA: a new imaging biomarker of neurodegeneration in multiple sclerosis?
Contralateral recurrence of tumefactive demyelination.
Changes and variability of proton density and T1 relaxation times in early multiple sclerosis: MRI markers of neuronal damage in the cerebral cortex.
Myopathy associated with Neuromyelitis Optica Spectrum Disorders.
The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management.
Variants of Interleukin-7/Interleukin-7 Receptor Alpha are Associated with Both Neuromyelitis Optica and Multiple Sclerosis Among Chinese Han Population in Southeastern China.
PSEUDOBULBAR AFFECT IN MULTIPLE SCLEROSIS PATIENTS.
[Treatment for multiple sclerosis in patients with collagen diseases].
Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention.
The ideal healthcare: priorities of people with chronic conditions and their carers.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Famous.
A survey of advice on driving in neurological conditions amongst neurologists and neurosurgeons.
Uptake of environmental toxicants by the locus ceruleus: A potential trigger for neurodegenerative, demyelinating and psychiatric disorders.
Pages
« first
‹ previous
…
588
589
590
591
592
593
594
595
596
…
next ›
last »